Perry Jade, Mennan Claire, Cool Paul, McCarthy Helen S, Newell Karin, Hopkins Timothy, Hulme Charlotte, Wright Karina T, Henson Frances M D, Roberts Sally
The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Oswestry, UK.
Centre of Regenerative Medicine Research, The School of Pharmacy and Bioengineering, Keele University, Staffordshire, UK.
Cartilage. 2024 Nov 3:19476035241287832. doi: 10.1177/19476035241287832.
To determine if mesenchymal stromal cells (MSCs) derived from human umbilical cords (hUC) could reduce degeneration developing when injected into the knee of a large animal model of osteoarthritis (OA).
Ten million culture-expanded UC-MSCs (pooled from 3 human donors) were injected in 50 μL of tissue culture medium into the left stifle joints of 7 sheep whose medial meniscus was transected 4 weeks previously. Seven other sheep had only 50 μL of medium injected as the no treatment "control" group. After 8 weeks the sheep underwent euthanasia, the joints were excised and examined macroscopically, via x-ray and magnetic resonance imaging (MRI), both via histology for degenerative and inflammatory changes and immunohistochemically to identify any human cells within the joint tissues. Activity monitoring both before meniscus transection and euthanasia was also undertaken.
There was a significant reduction in the Kellgren-Lawrence x-ray score for joints injected with hUC-MSCs compared with the control joints. Likewise, macroscopic, MRI, synovitis and OARSI histology scores were all lower (better) in the joints injected with hUC-MSCs than in the control arm, but not significantly. Activity levels and synovitis scores were similar in both groups of animals.
hUC-MSCs appear to modify and reduce the development of osteoarthritic changes in the ovine stifle joint after meniscal destabilization, an injury which commonly leads to OA in humans. These results are encouraging for the potential benefit of culture expanded UC-MSCs as an allogeneic cell therapy in patients who may have early OA following a meniscal injury of the knee.
确定源自人脐带(hUC)的间充质基质细胞(MSCs)注入大型骨关节炎(OA)动物模型的膝关节后是否能减少退变的发生。
将1000万个经培养扩增的脐带间充质干细胞(来自3名人类供体)用50μL组织培养基注入7只绵羊的左膝关节,这些绵羊4周前内侧半月板已横断。另外7只绵羊仅注入50μL培养基作为未治疗的“对照组”。8周后对绵羊实施安乐死,切除关节并进行宏观检查、X线和磁共振成像(MRI)检查,通过组织学检查退变和炎症变化,并通过免疫组织化学鉴定关节组织内的任何人类细胞。还在半月板横断前和安乐死时进行了活动监测。
与对照关节相比,注入脐带间充质干细胞的关节的凯尔格伦-劳伦斯X线评分显著降低。同样,注入脐带间充质干细胞的关节的宏观、MRI、滑膜炎和骨关节炎研究学会(OARSI)组织学评分均低于(更好)对照组,但差异不显著。两组动物的活动水平和滑膜炎评分相似。
在半月板失稳后,脐带间充质干细胞似乎能改变并减少绵羊膝关节骨关节炎变化的发展,半月板失稳是一种在人类中通常导致骨关节炎的损伤。这些结果对于培养扩增的脐带间充质干细胞作为同种异体细胞疗法对可能因膝关节半月板损伤而患有早期骨关节炎的患者的潜在益处而言是令人鼓舞的。